Cargando…

Crystal methamphetamine use in British Columbia, Canada: A cross-sectional study of people who access harm reduction services

INTRODUCTION: Increased use of crystal methamphetamine (“crystal meth”) has been observed across North America and international jurisdictions, including a notable increase in the presence of methamphetamines in illicit drug toxicity deaths in British Columbia (BC), Canada. We used data from a cross...

Descripción completa

Detalles Bibliográficos
Autores principales: Papamihali, Kristi, Collins, Dylan, Karamouzian, Mohammad, Purssell, Roy, Graham, Brittany, Buxton, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153500/
https://www.ncbi.nlm.nih.gov/pubmed/34038452
http://dx.doi.org/10.1371/journal.pone.0252090
_version_ 1783698812722741248
author Papamihali, Kristi
Collins, Dylan
Karamouzian, Mohammad
Purssell, Roy
Graham, Brittany
Buxton, Jane
author_facet Papamihali, Kristi
Collins, Dylan
Karamouzian, Mohammad
Purssell, Roy
Graham, Brittany
Buxton, Jane
author_sort Papamihali, Kristi
collection PubMed
description INTRODUCTION: Increased use of crystal methamphetamine (“crystal meth”) has been observed across North America and international jurisdictions, including a notable increase in the presence of methamphetamines in illicit drug toxicity deaths in British Columbia (BC), Canada. We used data from a cross-sectional survey and urine toxicology screening to report the prevalence, correlates, and validity of self-reported crystal meth use among clients of harm reduction sites in BC. MATERIALS AND METHODS: Survey data were collected from 1,107 participants across 25 communities in BC, through the 2018 and 2019 Harm Reduction Client Survey. We described reported substance use and used a multivariate logistic regression model to characterize crystal meth use. Urine samples provided by a subset of participants were used to derive validity of self-reported three-day crystal meth use compared to urine toxicology screening. RESULTS: Excluding tobacco, crystal meth was the most frequently reported substance used in the past three days in 2018 and 2019 (59.7% and 71.7%, respectively). Smoking was the dominant route of administration for crystal meth, crack, heroin, and fentanyl. Multivariate analysis determined significantly higher odds of crystal meth use among those who used opioids (Adjusted Odds Ratio [AOR] = 3.13), cannabis (AOR = 2.10), and alcohol (1.41), and among those who were not regularly housed (AOR = 2.08) and unemployed (AOR = 1.75). Age ≥50 was inversely associated with crystal meth use (AOR = 0.63). Sensitivity of self-reported crystal meth use was 86%, specificity was 86%, positive predictive value was 96%, and negative predictive value was 65%. CONCLUSIONS: Crystal meth was the most commonly used substance among clients of harm reduction sites in BC in 2018 and 2019, and was frequently used concurrently with opioids. Comparison to urine samples demonstrated high validity of self-reported crystal meth use. Understanding evolving patterns of substance use will be imperative in tailoring harm reduction and substance use services for individuals that use crystal meth.
format Online
Article
Text
id pubmed-8153500
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-81535002021-06-09 Crystal methamphetamine use in British Columbia, Canada: A cross-sectional study of people who access harm reduction services Papamihali, Kristi Collins, Dylan Karamouzian, Mohammad Purssell, Roy Graham, Brittany Buxton, Jane PLoS One Research Article INTRODUCTION: Increased use of crystal methamphetamine (“crystal meth”) has been observed across North America and international jurisdictions, including a notable increase in the presence of methamphetamines in illicit drug toxicity deaths in British Columbia (BC), Canada. We used data from a cross-sectional survey and urine toxicology screening to report the prevalence, correlates, and validity of self-reported crystal meth use among clients of harm reduction sites in BC. MATERIALS AND METHODS: Survey data were collected from 1,107 participants across 25 communities in BC, through the 2018 and 2019 Harm Reduction Client Survey. We described reported substance use and used a multivariate logistic regression model to characterize crystal meth use. Urine samples provided by a subset of participants were used to derive validity of self-reported three-day crystal meth use compared to urine toxicology screening. RESULTS: Excluding tobacco, crystal meth was the most frequently reported substance used in the past three days in 2018 and 2019 (59.7% and 71.7%, respectively). Smoking was the dominant route of administration for crystal meth, crack, heroin, and fentanyl. Multivariate analysis determined significantly higher odds of crystal meth use among those who used opioids (Adjusted Odds Ratio [AOR] = 3.13), cannabis (AOR = 2.10), and alcohol (1.41), and among those who were not regularly housed (AOR = 2.08) and unemployed (AOR = 1.75). Age ≥50 was inversely associated with crystal meth use (AOR = 0.63). Sensitivity of self-reported crystal meth use was 86%, specificity was 86%, positive predictive value was 96%, and negative predictive value was 65%. CONCLUSIONS: Crystal meth was the most commonly used substance among clients of harm reduction sites in BC in 2018 and 2019, and was frequently used concurrently with opioids. Comparison to urine samples demonstrated high validity of self-reported crystal meth use. Understanding evolving patterns of substance use will be imperative in tailoring harm reduction and substance use services for individuals that use crystal meth. Public Library of Science 2021-05-26 /pmc/articles/PMC8153500/ /pubmed/34038452 http://dx.doi.org/10.1371/journal.pone.0252090 Text en © 2021 Papamihali et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Papamihali, Kristi
Collins, Dylan
Karamouzian, Mohammad
Purssell, Roy
Graham, Brittany
Buxton, Jane
Crystal methamphetamine use in British Columbia, Canada: A cross-sectional study of people who access harm reduction services
title Crystal methamphetamine use in British Columbia, Canada: A cross-sectional study of people who access harm reduction services
title_full Crystal methamphetamine use in British Columbia, Canada: A cross-sectional study of people who access harm reduction services
title_fullStr Crystal methamphetamine use in British Columbia, Canada: A cross-sectional study of people who access harm reduction services
title_full_unstemmed Crystal methamphetamine use in British Columbia, Canada: A cross-sectional study of people who access harm reduction services
title_short Crystal methamphetamine use in British Columbia, Canada: A cross-sectional study of people who access harm reduction services
title_sort crystal methamphetamine use in british columbia, canada: a cross-sectional study of people who access harm reduction services
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153500/
https://www.ncbi.nlm.nih.gov/pubmed/34038452
http://dx.doi.org/10.1371/journal.pone.0252090
work_keys_str_mv AT papamihalikristi crystalmethamphetamineuseinbritishcolumbiacanadaacrosssectionalstudyofpeoplewhoaccessharmreductionservices
AT collinsdylan crystalmethamphetamineuseinbritishcolumbiacanadaacrosssectionalstudyofpeoplewhoaccessharmreductionservices
AT karamouzianmohammad crystalmethamphetamineuseinbritishcolumbiacanadaacrosssectionalstudyofpeoplewhoaccessharmreductionservices
AT purssellroy crystalmethamphetamineuseinbritishcolumbiacanadaacrosssectionalstudyofpeoplewhoaccessharmreductionservices
AT grahambrittany crystalmethamphetamineuseinbritishcolumbiacanadaacrosssectionalstudyofpeoplewhoaccessharmreductionservices
AT buxtonjane crystalmethamphetamineuseinbritishcolumbiacanadaacrosssectionalstudyofpeoplewhoaccessharmreductionservices